Newsbenzinga
Monte Rosa Therapeutics Investigational Drug Shows Potential for Cardiovascular Disease
· Published
Article summary
Monte Rosa Therapeutics reports positive Phase 1 trial data for MRT-8102 and outlines upcoming Phase 2 studies in inflammatory diseases.
An excerpt from the original article.
Comments —
Loading comments…